These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9362449)

  • 21. Functional interactions between isolated SH2 domains and insulin/Ras signaling pathways of Xenopus oocytes: opposite effects of the carboxy- and amino-terminal SH2 domains of p85 PI 3-kinase.
    Aroca P; Mahadevan D; Santos E
    Oncogene; 1996 Nov; 13(9):1839-46. PubMed ID: 8934529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling.
    Pronk GJ; de Vries-Smits AM; Ellis C; Bos JL
    Oncogene; 1993 Oct; 8(10):2773-80. PubMed ID: 8378086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
    Boerner JL; Danielsen AJ; Lovejoy CA; Wang Z; Juneja SC; Faupel-Badger JM; Darce JR; Maihle NJ
    Oncogene; 2003 Oct; 22(43):6679-89. PubMed ID: 14555981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases.
    Miki H; Miura K; Takenawa T
    EMBO J; 1996 Oct; 15(19):5326-35. PubMed ID: 8895577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration.
    Noguchi T; Matozaki T; Inagaki K; Tsuda M; Fukunaga K; Kitamura Y; Kitamura T; Shii K; Yamanashi Y; Kasuga M
    EMBO J; 1999 Apr; 18(7):1748-60. PubMed ID: 10202139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R.
    Jones N; Dumont DJ
    Oncogene; 1998 Sep; 17(9):1097-108. PubMed ID: 9764820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells.
    She HY; Rockow S; Tang J; Nishimura R; Skolnik EY; Chen M; Margolis B; Li W
    Mol Biol Cell; 1997 Sep; 8(9):1709-21. PubMed ID: 9307968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-induced tyrosine phosphorylation of a M(r) 70,000 protein revealed by association with the Src homology 2 (SH2) and SH3 domains of p120GAP and Grb2.
    Medema JP; Pronk GJ; de Vries-Smits AM; Clark R; McCormick F; Bos JL
    Cell Growth Differ; 1996 Apr; 7(4):543-50. PubMed ID: 9052995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
    Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
    Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Nck SH2/SH3 adaptor protein: a regulator of multiple intracellular signal transduction events.
    McCarty JH
    Bioessays; 1998 Nov; 20(11):913-21. PubMed ID: 9872057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential response of the Ras exchange factor, Ras-GRF to tyrosine kinase and G protein mediated signals.
    Shou C; Wurmser A; Suen KL; Barbacid M; Feig LA; Ling K
    Oncogene; 1995 May; 10(10):1887-93. PubMed ID: 7761090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the colony-stimulating factor 1 receptor leads to the rapid tyrosine phosphorylation of GTPase-activating protein and activation of cellular p21ras.
    Heidaran MA; Molloy CJ; Pangelinan M; Choudhury GG; Wang LM; Fleming TP; Sakaguchi AY; Pierce JH
    Oncogene; 1992 Jan; 7(1):147-52. PubMed ID: 1311060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The SH2/SH3 domain-containing protein Nck is recognized by certain anti-phospholipase C-gamma 1 monoclonal antibodies, and its phosphorylation on tyrosine is stimulated by platelet-derived growth factor and epidermal growth factor treatment.
    Meisenhelder J; Hunter T
    Mol Cell Biol; 1992 Dec; 12(12):5843-56. PubMed ID: 1448108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells.
    Yoon SY; Koh WS; Lee MK; Park YM; Han MY
    Biochem Biophys Res Commun; 1997 May; 234(3):539-43. PubMed ID: 9175747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDGF induction of tyrosine phosphorylation of GTPase activating protein.
    Molloy CJ; Bottaro DP; Fleming TP; Marshall MS; Gibbs JB; Aaronson SA
    Nature; 1989 Dec; 342(6250):711-4. PubMed ID: 2480526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins.
    Gold MR; Crowley MT; Martin GA; McCormick F; DeFranco AL
    J Immunol; 1993 Jan; 150(2):377-86. PubMed ID: 8419471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor increases protein and messenger RNA expression levels of Ras GTPase activating protein.
    Soler C; Felipe A; Carpenter G
    Cell Growth Differ; 1994 May; 5(5):519-26. PubMed ID: 8049158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
    Tanaka M; Gupta R; Mayer BJ
    Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.